Study of reactivation of resolved HBV in HBsAg-negative multiple myeloma patients after daratumumab treatment
Latest Information Update: 16 Apr 2021
At a glance
- Drugs Daratumumab (Primary)
- Indications Multiple myeloma
- Focus Adverse reactions
- 16 Apr 2021 New trial record
- 13 Apr 2021 Results published in the Clinical Infectious Diseases.